GLG News in Healthcare

Salmonella targeting cancer cells? In humans???

Saxagliptin is being studied in clinical trials as a once-daily therapy to determine its efficacy and safety. Saxagliptin was specifically designed to be a selective, reversible inhibitor of the DPP-4 enzyme, with dual routes of clearance. Phase III data for saxagliptin have previously been presented in combination with metformin, the most commonly prescribed oral anti-diabetic, as well as when used...

There is more to esthetics than just the use of   lasers and fillers...and a well trained plastic surgeon can give a far broader number of options to the patient than a  family physician or gynecologist If the derms want to do this skin rejuvenation....who is to treat rosacea,acne skin cancer and melanoma..... From an overall safety standpoint,the public is being put at risk by seeking...

without question, medicine has changed.  dermatologists and plastic surgeons can make considerably more money, and be paid in cash by catering to "cosmetic" patients.  No wonder fewer and fewer surgeons/dermatologists are interested in treating skin cancers, scars, lacerations etc.  Why get paid  25 cents on the dollar when you can get fee for service with patients interested in...

With excellent patient satisfaction, ease of use and excellent cash based reimbursement, there is a rapidly growing aesthetic & skin care business to dermatologic practice.  This has clearly impacted access to care by patients with skin disease in my area.  Perhaps a better question is why should we expect otherwise?

1.PrEP involves a prescription drug, so it’s likely that initial programs will be clinic-based. PrEP delivery would also require periodic HIV testing. 2. In contrast to male circumcision—or hopefully one day, a vaccine—PrEP would require that people take a drug on an ongoing basis (daily or intermittently). 3. Interest in PrEP could bring more individuals into the health clinic, where they would have...

While the clinical trial data remain unpublished, those who attended the ICAD conference remain concerned about the possibility that the effects are not as pronounced as the interpretation by the investigators.

Since treatment may be worse than the disease it is being recommended that routine prostate cancer screening be stopped after the age of 75.

There is already a bounty of data to support anti-retroviral (and other) HIV medications in post-exposure prophylaxis, be it in infants born to HIV-positive mothers; intra-partum prophylaxis to HIV-positive women in active labor; and to healthcare workers (and others) exposed to HIV from accidental needlesticks and other exposures.  Pre-exposure prophylaxis is simply a broadening of post-exposure...

 Should bisphosphonates be stopped in patients who have been taking them for many years?  Should they be used at all?